Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse

By            

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 2004-2008

Spandidos Publications

Access to resources Recommend Favorite

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

By Manenti L.   Paganoni P.   Floriani I.   Landoni F.   Torri V.   Buda A.   Taraboletti G.   Labianca R.   Belotti D.   Giavazzi R.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1948-1956

Elsevier

Access to resources Recommend Favorite

Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer*

By Tunuguntla R.   Ripley D.   Sang Q.-X.A.   Chegini N.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 453-459

Elsevier

Access to resources Recommend Favorite

Expression of matrix metalloproteinases and their inhibitors in human brain tumors

By Kachra Zarin   Beaulieu Edith   Delbecchi Louis   Mousseau Nathalie   Berthelet France   Moumdjian Robert   Del Maestro Rolando   Béliveau Richard  

Clinical and Experimental Metastasis, Vol. 17, Iss. 7, 1999-09 ,pp. : 555-566

Springer Publishing Company

Access to resources Recommend Favorite

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma

By Lu Hongsheng   Yang Zhaohui   Zhang Hui   Gan Meifu   Zhou Tao   Wang Siling  

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-03 ,pp. : 890-896

Spandidos Publications

Access to resources Recommend Favorite